Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | KR | 09 May 2023 | |
Neoplasms | Preclinical | KR | Therapex Co., Ltd.Startup | 09 May 2023 |